Anxiety in Patients with Neovascular Age-related Macular Degeneration

References

• Sabel BA, Wang J, Cárdenas-Morales L, Faiq M, Heim C. Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine. EPMA J. 2018;9(2):133–160. doi:10.1007/s13167-018-0136-8.
   PubMed Web of Science ®Google Scholar
• Taylor DJ, Smith ND, Jones PR, Binns AM, Crabb DP. Measuring dynamic levels of self-perceived anxiety and concern during simulated mobility tasks in people with non-neovascular age-related macular degeneration. Br J Ophthalmol. 2020;104:529–534.
   PubMedGoogle Scholar
• Olson D, Zhang X, Ward MF, et al. Rates of comorbid anxiety and depression in patients with age-related macular degeneration. J Vitreoretin Dis. 2019;3(4):211–214. doi:10.1177/2474126419849199.
   Google Scholar
• Rovner BW, Casten RJ, Hegel MT, et al. Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2014;121(11):2204–2211. doi:10.1016/j.ophtha.2014.05.002.
   PubMed Web of Science ®Google Scholar
• Mozaffarieh M, Sacu S, Benesch T, Wedrich A. Subretinal hemorrhages secondary to age-related macular degeneration: psychological and vision-related functional perspectives . Ophthalmologica. 2008;222(3):199–204. doi:10.1159/000126084.
   PubMedGoogle Scholar
• Lotery A, Xu X, Zlatava G, Loftus J. Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the uk cohort of a five-country cross-sectional study. Br J Ophthalmol. 2007;91(10):1303–1307. doi:10.1136/bjo.2007.116939.
   PubMed Web of Science ®Google Scholar
• Soubrane G, Cruess A, Lotery A, et al. Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol. 2007;125(9):1249–1254. doi:10.1001/archopht.125.9.1249.
   PubMed Web of Science ®Google Scholar
• Dawson SR, Mallen CD, Gouldstone MB. The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data. BMC Ophthalmol. 2014;14(14):78. doi:10.1186/1471-2415-14-78.
   PubMedGoogle Scholar
• Rovner BW, Casten RJ, Massof RW, Leiby BE, Tasman WS. Psychological and cognitive determinants of vision function in age-related macular degeneration. Arch Ophthalmol. 2011;129(7):885–890. doi:10.1001/archophthalmol.2011.146.
   PubMedGoogle Scholar
• Schmier JK, Covert DW, Lau EC. Patterns and costs associated with progression of age-related macular degeneration. Am J Ophthalmol. 2012;154(4):675–681. doi:10.1016/j.ajo.2012.04.017.
   PubMed Web of Science ®Google Scholar
• Jaffe DH, Shmueli A, Ben-Yehuda A, et al. Community healthcare in Israel: quality indicators 2007-2009. Isr J Health Policy Res. 2012;1(1):3. doi:10.1186/2045-4015-1-3.
   PubMedGoogle Scholar
• Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J. 2001;3:404–408.
   PubMed Web of Science ®Google Scholar
• Flug K. An overview of the middle class in Israel. (2012)
   Google Scholar
• Tzur Bitan D, Krieger I, Comaneshter D, Cohen AD, Feingold D. The association between the socioeconomic status and anxiety–depression comorbidity in patients with psoriasis: a nationwide population‐based study. J Eur Acad Dermatol Venereol. 2019;33(8):1555–1561. doi:10.1111/jdv.15651.
   PubMed Web of Science ®Google Scholar
• Jamal M, Van der Does AW, Cuijpers P, Penninx BW. Association of smoking and nicotine dependence with severity and course of symptoms in patients with depressive or anxiety disorder. Drug Alcohol Depend. 2012;126((1–2)):138–146. doi:10.1016/j.drugalcdep.2012.05.001.
   PubMedGoogle Scholar
• Faravelli C, Scarpato MA, Castellini G, Sauro CL. Gender differences in depression and anxiety: the role of age. Psychiatry Res. 2013;210(3):1301–1303. doi:10.1016/j.psychres.2013.09.027.
   PubMed Web of Science ®Google Scholar
• Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358(24):2606–2617. doi:10.1056/NEJMra0801537.
   PubMed Web of Science ®Google Scholar
• Kempen GI, Zijlstra GA. Clinically relevant symptoms of anxiety and depression in low-vision community-living older adults. Am J Geriatr Psychiatry. 2014;22(3):309e313. doi:10.1016/j.jagp.2012.08.007.
   Google Scholar
• Evans JR, Fletcher AE, Wormald RPL. Depression and anxiety in visually impaired older people. Ophthalmology. 2007;114(2):283e288. doi:10.1016/j.ophtha.2006.10.006.
   Google Scholar
• Cruess A, Zlateva G, Xu X, Rochon S. Burden of illness of neovascular age-related macular degeneration in Canada. Can J Ophthalmol. 2007;42(6):836–843. doi:10.3129/i07-153.
   PubMed Web of Science ®Google Scholar
• Ruiz-Moreno JM, Coco RM, García-Arumí J, Xu X, Zlateva G. Burden of illness of bilateral neovascular age-related macular degeneration in Spain. Curr Med Res Opin. 2008;24(7):2103–2111. doi:10.1185/03007990802214300.
   PubMed Web of Science ®Google Scholar
• Augustin A, Sahel JA, Bandello F, et al. Anxiety and depression prevalence rates in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48(4):1498–1503. doi:10.1167/iovs.06-0761.
   PubMedGoogle Scholar
• Dreiher J, Weitzman D, Shapiro J, Davidovici B, Cohen AD. Psoriasis and chronic obstructive pulmonary disease: a case-control study. Br J Dermatol. 2008;159:956–960.
   PubMed Web of Science ®Google Scholar
• Wohl Y, Dreiher J, Cohen AD. Pemphigus and dyslipidemia: a case-control study. Br J Dermatol. 2009;161(6):1418–1420. doi:10.1111/j.1365-2133.2009.09474.x.
   PubMedGoogle Scholar
• Dreiher J, Shapiro J, Cohen AD. Lichen planus and dyslipidemia: a case control study. Br J Dermatol. 2009;161(3):626–629. doi:10.1111/j.1365-2133.2009.09235.x.
   PubMedGoogle Scholar
• Berger V, Munk MR, Lersch F, Wolf S, Ebneter A, Zinkernagel MS. Association of intravitreal injections with blood pressure increase: the following excitement and anxiety response under intravitreal injection study. JAMA Ophthalmol. 2019;137(1):87–90. doi:10.1001/jamaophthalmol.2018.4892.
   PubMedGoogle Scholar
• Kayikcioglu O, Bilgin S, Seymenoglu G, Deveci A. State and trait anxiety scores of patients receiving intravitreal injections. Biomed Hub. 2017;2(2):1–5. doi:10.1159/000478993.
   PubMedGoogle Scholar
• Mimouni M, Abualhasan H, Mtanes K, Mazzawi F, Barak Y. Patients’ experience of anxiety and pain during retrobulbar injections prior to vitrectomy. J Ophthalmol. 2019;2019:1–5. doi:10.1155/2019/8098765.
   Google Scholar
• Boyle J, Vukicevic M, Koklanis K, Itsiopoulos C, Rees G. Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Psychol Health Med. 2018;23(2):127–140. doi:10.1080/13548506.2016.1274040.
   PubMed Web of Science ®Google Scholar
• Spooner KL, Mhlanga CT, Hong TH, Broadhead GK, Chang AA. The burden of neovascular age-related macular degeneration: a patient’s perspective. Clin Ophthalmol. 2018;12:2483. doi:10.2147/OPTH.S185052.
   PubMed Web of Science ®Google Scholar
• Baek SK, Kim JH, Kim JW, Kim CG. Increase in the population of patients with neovascular age-related macular degeneration who underwent long-term active treatment. Sci Rep. 2019;9(1):1–10. doi:10.1038/s41598-019-49749-y.
   PubMedGoogle Scholar
• Vogelzangs N, Beekman ATF, De Jonge P, Penninx BWJH. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013;3(4):249. doi:10.1038/tp.2013.27.
   PubMedGoogle Scholar
• Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the rpe-bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20(6):705–732. doi:10.1016/S1350-9462(01)00010-6.
   PubMed Web of Science ®Google Scholar
• Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res. 2001;73(6):887–896. doi:10.1006/exer.2001.1094.
   PubMed Web of Science ®Google Scholar
• Heesterbeek TJ, Lorés‐Motta L, Hoyng CB, Lechanteur YT, den Hollander AI. Risk factors for progression of age‐related macular degeneration. Ophthalmic Physiol Opt. 2020;40(2):140–170. doi:10.1111/opo.12675.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology. 2000;107(12):2224–2232‏. doi:10.1016/S0161-6420(00)00409-7.
   PubMed Web of Science ®Google Scholar
• Chatziralli I, Mitropoulos P, Parikakis E, Niakas D, Labiris G. Risk factors for poor quality of life among patients with age-related macular degeneration. Semin Ophthalmol. 2017;32(6):772–780. doi:10.1080/08820538.2016.1181192.
   PubMed Web of Science ®Google Scholar